C-MER Medical Holdings Limited
3309.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$898.5M
Close$
Share Statistics
| Market cap | $898.50 Million |
|---|---|
| Enterprise Value | $854.63 Million |
| Dividend Yield | $0.03 (3.97%) |
| Earnings per Share | $0.08 |
| Beta | 0.56 |
| Outstanding Shares | 1,189,224,504 |
Return
| Return on Equity | -0.85% |
|---|---|
| Return on Assets | -0.54% |
| Return on Invested Capital | 12.38% |
Valuation & Multiples
| P/E Ratio | 8.97 |
|---|---|
| PEG | 5816.04 |
| Price to Sales | 0.26 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | 2.96 |
| Enterprise Value to Net Income | -55 |
| Total Debt to Enterprise | 0.58 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 30, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About C-MER Medical Holdings Limited
2,200 employees
CEO: Xiaoting Li C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological servi...